Revision with unchanged content. While many text mining projects emphasize retrieval and extraction, text mining can be leveraged to discover new and previously unknown information. Nowhere is the potential more apparent than in pharmacogenomics-based drug discovery. Text mining can help pharmaceutical researchers reduce the vast information overload hindering pharmacogenomics-based drug discovery because it can aid in the generation of rich novel information from large collections of diverse scientific literature and research data. However the pharmaceutical industry appears to be reluctant to innovate bleeding-edge text mining technologies for drug discovery. The present book re-frames text mining as an approach to automate the generation of novel and interesting information, reviews successful exemplary text mining applications, and examines a case study of a leading pharmaceutical company within the book’s proposed novelty-generation paradigm. The present book is written for a wide range of professionals and scholars, not only for information scientists, industry analysts, and pharmaceutical executives, but also for those interested in innovation studies and the automated acceleration of discovery.
"synopsis" may belong to another edition of this title.
The author is Research Analyst and Chief Technologistfor the Jenkins Chair in New Technologies and Society at Duke University.
"About this title" may belong to another edition of this title.
Shipping:
US$ 32.28
From United Kingdom to U.S.A.
Shipping:
US$ 25.27
From Germany to U.S.A.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Revision with unchanged content. While many text mining projects emphasize retrieval and extraction, text mining can be leveraged to discover new and previously unknown infor mation. Nowhere is the potential more apparent than in pharmacogenomics-based drug discovery. Text mining can help pharmaceutical researchers reduce the vast information overload hindering pharmacogenomics-based drug discovery because it can aid in the generation of rich novel information from large collections of diverse scientific literature and research data. However the pharmaceutical industry appears to be reluctant to innovate bleeding-edge text mining technologies for drug discovery. The present book re-frames text mining as an approach to automate the generation of novel and interesting information, reviews successful exemplary text mining appli cations, and examines a case study of a leading pharma ceutical company within the book s proposed novelty-generation paradigm. The present book is written for a wide range of professionals and scholars, not only for infor mation scientists, industry analysts, and pharmaceutical executives, but also for those interested in innovation studies and the automated acceleration of discovery. 116 pp. Englisch. Seller Inventory # 9783639453393
Quantity: 2 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Revision with unchanged content. While many text mining projects emphasize retrieval and extraction, text mining can be leveraged to discover new and previously unknown infor mation. Nowhere is the potential more apparent than in pharmacogenomics-based drug discovery. Text mining can help pharmaceutical researchers reduce the vast information overload hindering pharmacogenomics-based drug discovery because it can aid in the generation of rich novel information from large collections of diverse scientific literature and research data. However the pharmaceutical industry appears to be reluctant to innovate bleeding-edge text mining technologies for drug discovery. The present book re-frames text mining as an approach to automate the generation of novel and interesting information, reviews successful exemplary text mining appli cations, and examines a case study of a leading pharma ceutical company within the book s proposed novelty-generation paradigm. The present book is written for a wide range of professionals and scholars, not only for infor mation scientists, industry analysts, and pharmaceutical executives, but also for those interested in innovation studies and the automated acceleration of discovery. Seller Inventory # 9783639453393
Quantity: 1 available
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Herron PatrickThe author is Research Analyst and Chief Technologistfor the Jenkins Chair in New Technologies and Society at Duke University.Revision with unchanged content. While many text mining projects emphasize retrieval and . Seller Inventory # 4989533
Quantity: Over 20 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: Like New. Like New. book. Seller Inventory # ERICA75836394533956
Quantity: 1 available